Healthcare professionals & pharmaceutical companies use RetinAI's software platform Discovery to manage their data, gain enhanced insights with automatic AI analysis and supercharge clinical and research workflows
A single data platform to manage & access your data anytime from anywhere. Compatible formats include DICOM-compliant and proprietary formats
Data is harmonized, organized, aggregated & analysed at scale using AI to extract insights about disease progression, treatment outcomes & progression prediction
Enable participative research accross your organization with a secured cloud-based access to data. The town square for data, medical and digital teams
View all your OCTs, Fundus images, DICOM datasets, PDFs, JPEG, PNG & TIFF files in one single place - no need for multiple viewers
Perform AI-based analysis on your OCTs volumes for layer & fluid segmentation
Provide immediate evaluation & centralize your insights in a single platform
Enrich your OCT with our AI models, providing quick access to volumetric analysis
Instantly invite collaborators to access and work with datasets with different permission levels
Easily upload multiple data formats from multiple imaging devices and data types
Apply expert-level, automatic AI technology to speed up your analysis
Collect all your data in a single platform with secure, cloud-based collaboration across your organisation and experts
Use annotations on particular dataset to teach or improve your artificial intelligence models
Access to a library of CE-marked biomarkers such as Fluid and Layer Segmentation Models
Access a library of experimental features and research use only models such as Geographic Atrophy Segmentation & Progression to power up your analysis
Our models and features are designed to support assessment of some of the most common vision-threatening diseases in ophthalmology: AMD, DR, DME, CME and GA
A single web platform for data collection and analysis, increasing data visibility and monitoring during the study and enabling stakeholders to make real-time decisions
Access automatic (AI) expert-level measurements for retinal thickness and fluid volume for real-time data analysis to accelerate a study‘s patient enrollment and pre-specified evaluations
Stakeholders with access to the platform can monitor enrollment, quality of data collected and overall study progress, saving time at every step
Centralize your data access control & manage who will access the data from your dashboard
Discovery is compliant with EU GDPR, HIPAA & Canadian PIPEDA rules for data privacy and security
Gather all data in a single platform to avoid any mistake
Use Discovery to aggregate datasets across multiple imaging types
Gain deeper insights into patient behaviours & disease progression with our AI models and advanced AI analytics
Understand patient behaviours and enable a data-driven understanding of disease progression
Easily upload multiple data formats from multiple imaging devices and data types
Easily organize your data into workbooks, making it simple to track all your patients' visits and acquisitions to evaluate trends
Get a more comprehensive view of health needs of patients to have an overall better patient care experience
Search your database of patients for target-based enrolment criteria with easy-to-use powered natural language queries
Categorize your patients into meaningful cohorts and subgroups based on phenotypical and clinical information
Generate real-time insights & analytics on real-world patient populations and clinical studies
Improve the healthcare decision process with one platform unifying and structuring data in a single ecosystem.
Empower decision makers with a decentralised approached for multi-modal image and data collection & management.
A modular & certified software solution providing you with access to AI for OCT and imaging data & the ability to present your work with colleagues and share data in a secure way and in real-time
Generate easy-to-read reports in a few minutes during the patient visit, and get support in the assessment of some of the most common vision-threatening diseases in ophthalmology: AMD, DR, DME, CME and GA* (in Research Use Only)
We are working with RetinAI and Discovery® provides an opportunity to efficiently collect, share and interpret images with advanced AI tools in a timely manner as the trial proceeds.
Together with RetinAI, we are working on end-to-end solutions to generate swift & comprehensive disease insights to better treat patients & improve patient outcomes.
Both my team and I are extremely impressed with the entire team. The project management and updates have been superb.
Discovery CORE® has changed my clinical research & enabled my multi-center collaborations, making it easy to work with colleagues and to do research.
See RetinAI’s products in action